Evidence map›Paper›PMID 38715569›Full record

ArticleBiologics : targets & therapy2024

Desi Reski Fajar, Tina Rostinawati, Laniyati Hamijoyo, Edhyana Sahiratmadja, Riezki Amalia, Melisa Intan Barliana

Abstract read
In one paragraph

Article in Biologics : targets & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Desi Reski FajarDepartment of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia.ORCID 0000-0002-0489-2996
Tina RostinawatiDepartment of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia.ORCID 0000-0002-7139-8250
Laniyati HamijoyoDivision of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran / Hasan Sadikin General Hospital, Bandung, Indonesia.ORCID 0000-0002-1310-674X
Edhyana SahiratmadjaImmunology Study Center, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.ORCID 0000-0001-9092-5848
Riezki AmaliaDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Jatinangor, Indonesia.ORCID 0000-0002-8445-7045
Melisa Intan BarlianaDepartment of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia.ORCID 0000-0003-0015-9604

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Systemic lupus erythematosus (SLE) is a complex autoimmune disease with numerous clinical manifestations. Organ involvement can aggravate patients with SLE and cause comorbidities such as atherosclerosis. Recently, the Patients and Methods: This case-control study included 84 SLE patients, of whom 21 patients with SLE with atherosclerosis and 63 patients with SLE without atherosclerosis. Using enzyme-linked immunosorbent assay method, interleukin-6 and interferon gamma levels were quantified. The Results: The genetic variations of Conclusion: The association of

Indexed as

atherosclerosisgenetic polymorphismLLDASsystemic lupus erythematosusTNFSF13B

Identifiers

PMID38715569
PMCPMC11075687

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.